Laurence Watts | Managing Director, Gilmartin Group LLC |
Talat Imran | CEO |
Svai Sanford | CFO |
Mir Hashim | Chief Scientific Officer |
Brandon Folkes | Cantor Fitzgerald |
Hao Shen | Bank of America |
Andreas Argyrides | Wedbush |
Annabel Samimy | Stifel |
Ashwani Verma | UBS |
Bert Hazlett | BTIG |
Mitchell Kapoor | H. C. Wainwright |
Hello, and welcome to Rani Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are a in a listen-only mode.
Following management's prepared remarks, we'll hold a Q&A session. To ensure that we have ample time to adjust everyone's questions during the Q&A session, we'll ask for a limit of one question and one follow-up question per person.
As a reminder, this call is being recorded today Wednesday, March 22, 2023.